ArticleMolecular cancer therapeutics2018

Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor-positive Breast Cancer.

Chrysiis Michaloglou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.